Skip to content

APOTHEEK VOSSELARE

Active Private limited companyfounded 2018active for 8 yearsLangemunt 95, 9850 DeinzeKBO/BCE: BE 0698.795.621 subsidiary of

Lifetime

7 annual accounts with figures on one time axis
peak of €159,115 in 2023
€138,106▲ 5.7%
lowest -€74,696 in 2019
€83,926▲ 8.4%
peak of €127,800 in 2025
€127,800▲ 31.9%
€435,933▼ 19.3%
peak of 0.6 FTE in 2019
0 FTE 
Board1 name since 2019
1 director
Owners
100%
Documentsfilings and deeds
30-06-202631 days before the deadline
2025abbreviated format
Equity from €96,874 to €127,800Debts from €539,924 to €435,933Cash from €106,999 to €73,070

Key points

from the 2025 annual accounts

Equity

€127,800 ▲ 31.9%

APOTHEEK VOSSELARE has made a profit without a break since 2020.

Debts

€435,933 77% of the balance sheet
Financial debts 49%Suppliers 10%Taxes and wages 2%Other 39%

€272,151 of the debts are secured on the company's own assets. In 2021 that was €504,885.

Filings

7 annual accounts 3 late
AprilJune31 JulyOctober202020222024

The 2021 accounts came in latest, 75 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,684 companies had the same profile as APOTHEEK VOSSELARE has now. Each dot stands for 7 companies, two years later.

97.3%
were still trading
1.3%
stopped another way
1.3%
went bankrupt
  • Small
  • 5 to 10 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,684 companies, not a prediction for APOTHEEK VOSSELARE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager,
  • 100%score equity €150,500 (2026) · annual accounts 31-03-2026 of
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0698795621
Company renamed from APOTHEEK VAN GANSBEKE - VOSSELARE to APOTHEEK VOSSELARE acts as permanent representative · Gazette deed
Registered office moved from Lievegem to Nevele The registered office moved from Pastoor Moernautstraat 20, 9921 LIEVEGEM to Lange Munt 95, 9850 Nevele · appointed as manager · and act as permanent representatives · General meeting of 25-09-2019 · Gazette deed
Incorporation Founding capital of €20,000, 2,000 shares · Founded by ; · appointed as manager · published on 28-06-2018 · Gazette deed
All 15 events

Comparable companies

same main activity, similar in size and age
Company
APOTHEEK VOSSELARE Deinze €563,733 €138,106 22.7% 0
AM INVESTMENT-APOTHEEK VAN SYMAEYS Avelgem €519,305 €123,992 35.3% 0
MILPHARMA Riemst €502,955 €133,781 28.1% 0
Stella and Maynard Ghent €597,024 €160,946 64.2% 0
DUO-PHARMA Orp-Jauche €479,265 €145,378 12.8% 0
Apotheek Rhode Merelbeke-Melle €582,026 €153,685 58.1% 0
Apotheek Debruyne Klaas Middelkerke €479,137 €155,322 67.0% 0

These companies have the same main activity as APOTHEEK VOSSELARE: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €479,000 and €597,000, founded between 2014 and 2017.

Official details

Source: KBO
Status
Active since 26-06-2018Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.277.319.6769850 Deinze, registered on 26-06-2018
Financial year end
31 December
Peppol
Reachable since 12-12-2025
Company details

Annual accounts 2025

≈ €650,000estimated
€563,733▼ 11.5%
Filing
Filed on 30-06-2026, 31 days before the end of the filing period
Financials

Insights on APOTHEEK VOSSELARE

APOTHEEK VOSSELARE files the abbreviated format. That format states no turnover. The gross margin rose from €29,636 in 2019 to €138,106 in 2025.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about APOTHEEK VOSSELARE

What is the company number of APOTHEEK VOSSELARE?
The company number of APOTHEEK VOSSELARE is 0698.795.621. The VAT number is the same number with BE in front: BE 0698.795.621.
Where is APOTHEEK VOSSELARE based?
The registered office is at Langemunt 95, 9850 Deinze.Company details
What does APOTHEEK VOSSELARE do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK VOSSELARE?
APOTHEEK VOSSELARE is a private limited company (BV).
When was APOTHEEK VOSSELARE founded?
APOTHEEK VOSSELARE was founded on 26-06-2018.
Is APOTHEEK VOSSELARE still active?
Yes, APOTHEEK VOSSELARE is an active enterprise in the KBO register.
How many employees does APOTHEEK VOSSELARE have?
APOTHEEK VOSSELARE had an average of 0.6 full-time equivalents in financial year 2019, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK VOSSELARE?
The turnover in financial year 2025 is about €650,000. This figure is estimated from the gross margin of €138,106 and 43 comparable companies (NACE 477). It probably lies between €420,000 and €1.4m.
Is APOTHEEK VOSSELARE profitable?
In financial year 2025, APOTHEEK VOSSELARE made a profit of €83,926.
Where can I find the annual accounts of APOTHEEK VOSSELARE?
APOTHEEK VOSSELARE filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK VOSSELARE due?
APOTHEEK VOSSELARE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.